Juan Michael Porter II of TheBody Discusses Future of Science, Founder's Syndrome and Inclusivity at International Meeting | AIDS 2024

Results presented at the 25th AIDS Conference showed that switching to Biktarvy resulted in approximately twice as much weight gain, on average, than switching to Dovato.

Here’s what you missed this week on Managed Healthcare Executive.

Today, the clade 2b outbreak has reached alarming proportions, with over 94,000 confirmed cases reported across 117 countries, including significant numbers in the U.S. and Brazil, and up to 103 deaths. The virus has been found to affect younger men who have sex with men, who are linked to high rates of HIV co-infection.

Juan Michael Porter II, a prominent healthcare journalist and HIV advocate, spoke to MHE about keeping HIV/AIDS a priority and the dynamics of funding programs and pharmaceutical pricing

Keri Althoff, Ph.D., discusses how a model developed at Johns Hopkins can assess the comorbidities that patients with HIV may face by 2030.

Improving equity for people with HIV requires health leaders to recognize that patients have different risk factors, Keri Althoff, Ph.D., of Johns Hopkins says.